BioMar (BIOMAR) Q4 2024 earnings summary

Executive summary

• Achieved record-high EBITDA of DKK 1,476 million in 2024, up 18% year-over-year, despite a 5% decline in volumes and 7% lower revenue to DKK 16.6 billion, driven by strategic focus on profitability and product excellence.

• EBIT rose 31% to DKK 1,129 million, and net profit increased 46% to DKK 706 million compared to 2023.

• Strong cash flow from operating activities at DKK 1,585 million, up DKK 920 million from 2023, with significant reduction in net interest-bearing debt to DKK 1,577 million.

• Strategic initiatives included segment restructuring, digitalisation, and investments in technology and sustainability.

Financial highlights

• Revenue: DKK 16,616 million (down 7% year-over-year).

• EBITDA: DKK 1,476 million (up 18% year-over-year).

• EBIT: DKK 1,129 million (up 31% year-over-year).

• Net profit: DKK 706 million (up 46% year-over-year).

• ROIC including goodwill: 21.2% (up from 17.5% in 2023).

• Working capital reduced to DKK 1,671 million from DKK 2,141 million.

• Net interest-bearing debt reduced to DKK 1,577 million from DKK 2,531 million.

Outlook and guidance

• 2025 revenue expected at DKK 16.0–17.0 billion; EBITDA guidance of DKK 1,470–1,570 million.

• Share of profit after tax from JVs and associates expected to improve to approximately DKK 80 million.

• Continued investments in digitalisation and manufacturing systems to drive efficiency and transparency.